Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
jeudi, novembre 19
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Encompass Health Corp
EHC
NYSE
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$130.89
-4.04
-2.99%
Dern. MÀJ: Nov 19, 11:01 AM
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Dividendes
Comparer
Rapport sur les stocks
Encompass Health Financials
Encompass Health (EHC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Encompass Health Says Sea Pines Rehabilitation Hospital Closed Indefinitely After Torrential Rains; Co. Reaffirms FY26 Guidance Provided On Oct. 28
On Nov. 1-2, 2026, sustained torrential rains led to the flooding, evacuation and closure of Sea Pines Rehabilitation Hospital in Melbourne, Florida ("Sea Pines"). Sea Pines is a 90-bed hospital owned by a joint
Benzinga Newsdesk
PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $6.02-$6.25 to $6.23-$6.37 vs $6.11 Est; Raises FY2026 Sales Guidance from $6.410B-$6.490B to $6.450B-$6.500B vs $6.460B Est
Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $6.02-$6.25 to $6.23-$6.37 vs $6.11 analyst estimate. Raises FY2026 sales outlook from $6.410 billion-$6.490 billion to $6.450 billion-$6.500 billion vs
Benzinga Newsdesk
PRO
Encompass Health Q3 Adj. EPS $1.52 Beats $1.36 Estimate, Sales $1.609B Beat $1.601B Estimate
Encompass Health (NYSE:EHC) reported quarterly earnings of $1.52 per share which beat the analyst consensus estimate of $1.36 by 11.76 percent. This is a 23.58 percent increase over earnings of $1.23 per share from the
Benzinga Newsdesk
PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.375B-$6.470B to $6.410B-$6.490B vs $6.421B Est
Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.375 billion-$6.470 billion to $6.410 billion-$6.490 billion vs
Benzinga Newsdesk
PRO
Encompass Health Q2 Adj. EPS $1.55 Beats $1.48 Estimate, Sales $1.597B Beat $1.571B Estimate
Encompass Health (NYSE:EHC) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.48 by 4.73 percent. This is a 10.71 percent increase over earnings of $1.40 per share from the
Benzinga Newsdesk
PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.365B-$6.465B to $6.375B-$6.470B vs $6.423B Est
Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.365 billion-$6.465 billion to $6.375 billion-$6.470 billion vs
Benzinga Newsdesk